Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Singular Genomics Systems, Inc. - Common Stock (NQ: OMIC )

19.70 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Singular Genomics Systems, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Singular Genomics to Report Second Quarter 2023 Financial Results on August 9, 2023
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for... 
Via Benzinga
Recap: Singular Genomics Sys Q1 Earnings
Via Benzinga
Singular Genomics Sys's Earnings Outlook
Via Benzinga
Earnings Outlook For Singular Genomics Systems
Via Benzinga
4 Analysts Have This to Say About Singular Genomics Sys
  Analysts have provided the following ratings for Singular Genomics Sys (NASDAQ:OMIC) within the last quarter: 
Via Benzinga
Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Recent Highlights and First Quarter 2023 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Report First Quarter 2023 Financial Results on May 9, 2023
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Present at Cowen’s 43rd Annual Health Care Conference
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Launches Max Read™ Kits for Single Cell Sequencing on the G4 at AGBT
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT
The datasets are the latest to validate the performance and plug-and-play capability of the G4 across multiple applications 
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Joins the 10x Genomics Compatible Partner Program
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's session, 107 stocks hit new 52-week lows. 
Via Benzinga
Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results
From Singular Genomics Systems, Inc.
Via GlobeNewswire
A Preview Of Singular Genomics Systems's Earnings
Singular Genomics Systems (NASDAQ:OMIC) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022
From Singular Genomics Systems, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus... 
Via Benzinga
Apple To $220? Here Are 5 Other Price Target Changes For Wednesday
Wedbush raised the price target on Apple Inc. (NASDAQ: AAPL) from $200 to $220. However, Wedbush analyst Daniel Ives maintained the stock with an Outperform. Apple shares fell 0.2% to $172.69 in... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 17, 2022
  
Via Benzinga
Analyzing Singular Genomics Systems Short Interest
Singular Genomics Systems (NASDAQ:OMIC) short percent of float has fallen 8.6% since its last report. The company recently reported that it has 2.77 million shares sold... 
Via Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. 
Via Benzinga
Nasdaq Surges Over 300 Points; Trade Desk Shares Spike Higher
U.S. stocks traded higher toward the end of trading, following the release of inflation data. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.